Search results
The life-saving health tests every middle-aged man should have even if they hate the doctor
The Telegraph via Yahoo News· 6 days agoMen die four to six years younger than women on average, according to government figures. Alongside...
Stocks to Buy: 3 Biotech Bargains Delivering Breakthroughs on a Budget
InvestorPlace· 3 days agoFundamentally, biotech stocks to buy operate on a clear and unavoidable narrative: wealth means...
The Shifting Epidemiology of Hypercholesterolemia
MedPage Today· 4 days agoThe epidemiology of hypercholesterolemia has been shifting in recent years. The optimal total cholesterol level is defined as about 150 mg/dL, putting low-density lipoprotein (LDL) cholesterol ...
Ultragenyx Pharmaceutical (NASDAQ:RARE) Rating Reiterated by Cantor Fitzgerald
ETF DAILY NEWS· 3 days agoUltragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report)‘s stock had its “overweight” rating reiterated by research analysts at Cantor Fitzgerald in a report released on Wednesday, Benzinga ...
Madrigal Pharmaceuticals's Options Frenzy: What You Need to Know - Madrigal Pharmaceuticals...
Benzinga· 4 days agoThe product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis ...
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives $9.33 Consensus Target Price from Analysts
ETF DAILY NEWS· 5 days agoEsperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) has earned an average rating of “Hold” from the five analysts that are currently covering the company, MarketBeat reports. Three research ...
Esperion Therapeutics Target of Unusually High Options Trading (NASDAQ:ESPR)
ETF DAILY NEWS· 5 days agoEsperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) saw some unusual options trading activity on Monday. Investors bought 5,316 call options on the stock. This represents an increase ...
GSA Capital Partners LLP Raises Holdings in Esperion Therapeutics, Inc. (NASDAQ:ESPR)
ETF DAILY NEWS· 3 days agoGSA Capital Partners LLP increased its holdings in Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 1.0% in the 4th quarter, according to its most recent disclosure with the SEC. The ...
Ultragenyx Pharmaceutical (NASDAQ:RARE) Shares Gap Down Following Insider Selling
ETF DAILY NEWS· 3 days agoUltragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report)’s share price gapped down prior to trading on Thursday following insider selling activity. Ultragenyx Pharmaceutical shares last ...